NetworkNewsBreaks Archive - Page 1956 of 2081

FridayAug 11, 2017 9:58 am

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Soars on Private Placement, Canceled Deal with Kalani Investments

Coming off an earlier trading halt, shares of DryShips (NASDAQ: DRYS) are up 84% following news the company will sell its common shares to entities affiliated with its chairman and CEO, George Economou, for aggregate consideration of $100 million at a price of $2.75 per share. The board's Audit Committee also approved a subsequent rights offering that would allow DryShips shareholders to purchase their pro rata portion of up to $100 million of the Company's common shares at a price of $2.75 per share. The Rights Offering will be backstopped in full by Sierra Investments Inc., an entity affiliated with…

FridayAug 11, 2017 9:30 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE MKT: IGC) May Hold Blockbuster Position for Alzheimer’s Treatment

Savvy investors should be keeping a close eye on some key developments that have taken place within the past year relating to Alzheimer’s disease, medical cannabis, and India Globalization Capital (NYSE MKT: IGC). These developments include exciting, if preliminary, results relating to the effect of THC on amyloid-beta plaques—which are the plaques on neurons associated with Alzheimer’s disease—and a critical link between the related technology and IGC. "This information was summarized in an article first published on Benzinga (http://nnw.fm/6SSZi) and recently adapted for HIGH TIMES (http://nnw.fm/7AZcm), titled 'Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work.' “Details from these…

FridayAug 11, 2017 9:24 am

NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Prices $20M Public Offering

EnteroMedics (NASDAQ:ETRM), a developer of minimally invasive medical devices for the treatment of obesity, metabolic diseases and other gastrointestinal disorders, this morning priced its underwritten public offering of 20,000 units at a price to the public of $1,000 per unit. The gross proceeds to EnteroMedics is expected to be $20 million. A total of 20,000 shares of preferred stock convertible into 8.7 million shares of common stock, and warrants to purchase 8.7 million shares of common stock will be issued in the offering. The closing of the offering is expected to take place on or about August 16, 2017. To…

ThursdayAug 10, 2017 2:58 pm

NetworkNewsBreaks – Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: IMH) Provides Update on Harvesting

Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: IMH) today announced the completion of its wholly owned subsidiary’s first two harvests earlier this month. Both harvests exceeded expectations and two more harvests are expected the first week of September. Additionally, the company reported that the 27,800 sq. ft. production facility currently under construction is scheduled for completion by the end of January 2018. The additional space is projected to increase production by 800%. Dan Kriznic, Chairman & CEO, Invictus MD, commented, "Invictus MD is well capitalized for expansion with approximately $28.5 million in cash and is prepared for an exciting year of…

ThursdayAug 10, 2017 12:08 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 10, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CYAN 24.46% – News: Posts fiscal Q1 2018 financial results LUNA 16.53% – News: Posts Q2, first half 2017 financial results IDND 11.11% – News: Qiagen utilizes The Answer® to dispense nuclease-free water for molecular testing RADA 9.79% – News: Posts Q2 2017 financial results, hosts conference call TRCK 7.14% – News: Posts fiscal Q3 2017 financial results MACE 6.20% – News: Posts Q2, first half 2017 unaudited financial results DYSL 5.78% – News:…

ThursdayAug 10, 2017 9:53 am

NetworkNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Bioceres’ Joint Venture Receives Completed Safety Review by FDA

Arcadia Biosciences (NASDAQ: RKDA) before the bell said its joint venture with Bioceres S.A., Verdeca, has received notification that the FDA has completed its full review of the company’s safety evaluation for HB4 soybeans. This permits Verdeca products derived from HB4 soybeans to be used commercially in human food and animal feed. Additionally, completion of the FDA’s review marks a key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The company has submitted an environmental safety data petition to the U.S. Department of Agriculture (USDA) which is currently under review. The USDA is expected to…

ThursdayAug 10, 2017 9:49 am

NetworkNewsBreaks – Data and Safety Monitoring Board Recommends Completion of ARCA biopharma, Inc.’s (NASDAQ: ABIO) GENETIC-AF Trial

ARCA biopharma (NASDAQ: ABIO) this morning said the GENETIC-AF trial Data and Safety Monitoring Board (DSMB) has completed its pre-specified phase 2B interim analysis and has recommended completion of the study with no changes to the trial design. GENETIC-AF is a clinical trial evaluating Gencaro™ as a candidate for the treatment of atrial fibrillation (AF). The Gencaro development program has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). “The DSMB stated that there were no safety concerns and that the efficacy results met the prespecified criteria for continuing the Phase 2B trial to completion. We…

ThursdayAug 10, 2017 9:46 am

NetworkNewsBreaks – SeeThruEquity Issues Update, New PT on IEG Holdings Corp. (IEGH)

SeeThruEquity has updated its coverage and issued a new price target of $5.20 on shares of IEG Holdings Corp.’s (OTCQB: IEGH) stock following the company’s recent release of financial results for the second quarter of 2017. Among other highlights, the analyst noted that the results showed a decrease in operating costs as well as an improved balance sheet for IEG. Additionally, the company declared a cash dividend of $0.005 per common share for the second quarter of 2017. The dividend is payable on August 21, 2017, to stockholders of record at the close of business on Friday, August 11, 2017.…

ThursdayAug 10, 2017 9:32 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

WednesdayAug 09, 2017 12:44 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on August 9, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RHNO 19.82% – News: Posts Q2 2017 financial results CNXR 13.98% – News: Releases results of consumer survey regarding health insurance CUI 13.27% – News: Posts unaudited Q2 2017 financial results BONL 12.36% – News: Posts fiscal Q1 2018 profits EFOI 10.99% – News: Posts Q2 2017 financial results VCEL 10.00% – News: Posts Q2 2017 financial results NIHD 9.16% – News: Posts Q2 2017 financial results PNAT 8.93% – News: Launches Pura Pro…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks